UK criticised for relying on Tamiflu
The UK government's reliance on Tamiflu for fighting
bird flu has been criticised by an independent UK expert
The Society noted that the H5N1 bird flu virus may become resistant to the
drug over time.
Most global governments are currently stockpiling large amounts of the drug
as preparation for a future pandemic. But the Royal Society is skeptical about
this single-track strategy.
In its Pandemic Influenza Report
, the Royal Society criticises the
British government for not sufficiently considering recent scientific
developments in preparations for future avian flu management.
The Society believes that exclusive reliance on any single drug, or type of
drug, is very risky. It has encouraged governments to consider sensible
diversification strategies, including the development and stockpiling of new
drug classes and vaccines.
To comment, login here
Or register to be able to comment.